IP Library Granted Patent US 9,165,119
Granted Patent B2
US 9,165,119 · App. 12/996,989 · Granted Oct 20, 2015

Power injector with keep vein open functionality

Inventor: Andrew H. Kasako (Springdale, OH)
Assignee: LIEBEL-FLARSHEIM COMPANY LLC
G06F19/3468A61M5/14546A61B6/548A61M5/007A61M2005/1404A61M2005/14208A61M2005/14553G06F19/321
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,165,119
App. No.
12/996,989
Granted
Oct 20, 2015
Kind
B2
Abstract

Disclosed are systems and methods for power injectors incorporating a keep vein open functionality that is operable when an injection protocol ( 112 ) is suspended. The injector includes control logic ( 110 ) configured to include the injection protocol ( 112 ), and a separate drip mode injection protocol ( 114 ) executable only during a suspension of the injection protocol ( 112 ). In one embodiment, the drip mode injection protocol ( 114 ) is automatically or manually initiated immediately after and in response to the suspension of the injection protocol ( 112 ). In another embodiment, the drip mode injection protocol ( 114 ) is automatically initiated after a predetermined delay from start of the suspension of the injection protocol ( 112 ). The configuration parameters for the drip mode injection protocol ( 114 ) may be programmable prior to the initiation of an injection procedure, immediately prior to the execution of the drip mode injection protocol ( 114 ), or hard-coded into the injector.

Claims (44)

1. A power injector comprising:

a syringe plunger driver comprising a motorized drive source;

a first syringe comprising a first plunger;

a first fluid in said first syringe, wherein said first fluid is contrast media;

a second syringe comprising a second syringe plunger;

a second fluid in said second syringe, wherein said second fluid is different from said first fluid; and

power injector control logic comprising:

an injection protocol, wherein said injection protocol comprises a first programmed sequence;

a drip mode injection protocol, wherein said drip mode injection protocol comprises a second programmed sequence that is not part of said first programmed sequence such that said injection protocol excludes said drip mode injection protocol, wherein said injection protocol and said drip mode injection protocol are mutually exclusive in that only one of said injection protocol and said drip mode injection protocol can control operation of said power injector at any one time, wherein said injection protocol consists of a set of phases that excludes said drip mode injection protocol, wherein each said phase of said injection protocol comprises a programmed volume of a specified fluid that is delivered at a programmed flow rate, wherein said set of phases for said injection protocol comprises first and second phases, wherein said first phase delivers said first fluid from said first syringe, wherein said second phase delivers said second fluid from said second syringe, and wherein said drip mode injection protocol is configured to deliver a low flow rate injection of a small volume of said second fluid from said second syringe to keep open fluid communication between said power injector and a patient;

a logic operator, wherein said logic operator is configured to transfer control from said injection protocol to said drip mode injection protocol upon an occurrence of and in response to a first condition, wherein said first condition comprises a suspension of said injection protocol that is identified by said power injector;

a graphical user interface; and

a first prompt presented on said graphical user interface to initiate said drip mode injection protocol, wherein presentation of said first prompt is in response to an identified occurrence of said suspension of said injection protocol by said power injector, wherein said drip mode injection protocol is manually initiated by receipt of user input to said first prompt, wherein execution of said injection protocol resumes after termination of said drip mode injection protocol, and wherein said syringe plunger driver is operated: 1) to advance said first plunger of said first syringe in a fluid discharge direction for said first phase of said injection protocol; 2) to advance said second plunger of said second syringe in a fluid discharge direction for said second phase of said injection protocol; and 3) to advance said second plunger of said second syringe in said fluid discharge direction for said drip mode injection protocol.

2. A power injector comprising:

a syringe plunger driver comprising a motorized drive source;

a first syringe comprising a first plunger;

a first fluid in said first syringe, wherein said first fluid is contrast media;

a second syringe comprising a second syringe plunger;

a second fluid in said second syringe, wherein said second fluid is different from said first fluid; and

power injector control logic comprising:

an injection protocol, wherein said injection protocol comprises a first programmed sequence;

a drip mode injection protocol, wherein said drip mode injection protocol comprises a second programmed sequence that is not part of said first programmed sequence such that said injection protocol excludes said drip mode injection protocol, wherein said injection protocol and said drip mode injection protocol are mutually exclusive in that only one of said injection protocol and said drip mode injection protocol can control operation of said power injector at any one time, wherein said injection protocol consists of a set of phases that excludes said drip mode injection protocol, wherein each said phase of said injection protocol comprises a programmed volume of a specified fluid that is delivered at a programmed flow rate, wherein said set of phases for said injection protocol comprises first and second phases, wherein said first phase delivers said first fluid from said first syringe, wherein said second phase delivers said second fluid from said second syringe, and wherein said drip mode injection protocol is configured to deliver a low flow rate injection of a small volume of said second fluid from said second syringe to keep open fluid communication between said power injector and a patient; and

a drip mode injection protocol trigger condition, wherein said drip mode injection protocol trigger condition comprises a suspension of said injection protocol that is identified by said power injector, wherein satisfaction of said drip mode injection protocol trigger condition allows for execution of said drip mode injection protocol, wherein said drip mode injection protocol is automatically initiated after expiration of a predetermined delay following an identified occurrence of said suspension of said injection protocol by said power injector, wherein execution of said injection protocol resumes after termination of said drip mode injection protocol, and wherein said syringe plunger driver is operated: 1) to advance said first plunger of said first syringe in a fluid discharge direction for said first phase of said injection protocol; 2) to advance said second plunger of said second syringe in a fluid discharge direction for said second phase of said injection protocol; and 3) to advance said second plunger of said second syringe in said fluid discharge direction for said drip mode injection protocol.

3. The power injector of claim 2 , wherein said injection protocol is configurable.

4. The power injector of claim 2 , further comprising:

a graphical user interface, wherein at least one of said injection protocol and said drip mode injection protocol may be configured through said graphical user interface.

5. The power injector of claim 2 , wherein said drip mode injection protocol is configurable after said suspension of said injection protocol.

6. The power injector of claim 2 , wherein said drip mode injection protocol is hard-coded.

7. The power injector of claim 2 , wherein said drip mode injection protocol is configurable prior to execution of said injection protocol.

8. A method of operation for a power injector comprising:

executing an injection protocol, wherein said injection protocol comprises a first programmed sequence, wherein said injection protocol consists of a set of phases that excludes a drip mode injection protocol, wherein each said phase of said injection protocol comprises a programmed volume of a specified fluid that is delivered at a programmed flow rate, wherein said set of phases for said injection protocol comprises first and second phases, wherein execution of said first phase comprises operating a syringe plunger driver of said power injector to advance a first plunger of a first syringe in a fluid discharge direction to discharge a first fluid out of said first syringe, wherein execution of said second phase comprises operating said syringe plunger driver of said power injector to advance a second plunger of a second syringe in a fluid discharge direction to discharge a second fluid out of said second syringe, wherein said second fluid is different from said first fluid, and wherein said first fluid is contrast media;

monitoring for a suspension of said injection protocol;

issuing a prompt to initiate said drip mode injection protocol in response to said suspension having been identified by said monitoring step, wherein said prompt is presented on a graphical user interface;

receiving user input in relation to said prompt; and

executing said drip mode injection protocol in response to said user input, wherein said executing said drip mode injection protocol step comprises operating said syringe plunger driver of said power injector to advance said second plunger of said second syringe in said fluid discharge direction to discharge said second fluid out of said second syringe, wherein said drip mode injection protocol comprises a second programmed sequence that is not part of said first programmed sequence such that said injection protocol excludes said drip mode injection protocol, wherein said injection protocol and said drip mode injection protocol are mutually exclusive in that only one of said injection protocol and said drip mode injection protocol can control operation of said power injector at any one time, wherein said drip mode injection protocol is configured to deliver a low flow rate injection of a small volume of said second fluid out of said second syringe to keep open fluid communication between said power injector and a patient, and wherein said executing an injection protocol step, said monitoring step, said issuing a prompt step, said receiving step, and said executing said drip mode injection protocol step are all done by said power injector.

9. The method of claim 8 , further comprising:

configuring said injection protocol prior to said executing an injection protocol step.

10. The method of claim 9 , wherein said configuring said injection protocol step is executed through said graphical user interface.

11. The method of claim 8 , further comprising:

configuring said drip mode injection protocol after said suspension is identified by said monitoring step.

12. The method of claim 11 , wherein said configuring said drip mode injection protocol step is executed through said graphical user interface.

13. The method of claim 8 , wherein said drip mode injection protocol is hard-coded.

14. The method of claim 8 , further comprising:

configuring said drip mode injection protocol before said executing an injection protocol step.

15. The method of claim 14 , wherein said configuring a drip mode injection protocol step is executed through said graphical user interface.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2010
From: KASAKO, ANDREW H.
To: MALLINCKRODT INC.
Reel/Frame 025483/0791 →
Continuity (2)
Provisional Application 61091751 · Aug 26, 2008
Related Publication 20110137161A1 · Jun 9, 2011